Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection.

Disha BhavsarGagandeep SinghKaori SanoCharles GleasonKomal Srivastavanull nullJuan Manuel CarrenoViviana SimonFlorian Krammer

Published in: mBio (2023)

Antibodies on mucosal surfaces of the upper respiratory tract have been shown to be important for protection from infection with SARS-CoV-2. Here we investigate the induction of serum IgG, saliva IgG, and saliva sIgA after COVID-19 mRNA booster vaccination or breakthrough infections.

Keyphrases

sars cov
respiratory tract
respiratory syndrome coronavirus
ulcerative colitis
coronavirus disease
binding protein
staphylococcus aureus
cystic fibrosis